U.S., May 31 -- ClinicalTrials.gov registry received information related to the study (NCT06996236) titled 'Brimonidine Eye Drops in the Prevention of Myopia Progression' on April 22.
Brief Summary: Study to determine the efficacy of alpha-2 adrenergic drugs (brimonidine) in the prevention of myopia progression. Given that the drugs used so far have limited efficacy and side effects (loss of near vision, photophobia), it may be an interesting contribution to such treatment at low cost, and to avoid the expense of managing the complications of myopia that develop throughout life.
Study Start Date: July, 2025
Study Type: INTERVENTIONAL
Condition:
Myopia
Intervention:
DRUG: Treatment with brimonidine eye drops 0.025%
Treatment with bri...